We are live on ! Find out more
CCXI

ChemoCentryx, Inc.

Delisted

CCXI was delisted on the 19th of October, 2022.

71 hedge funds and large institutions have $61.3M invested in ChemoCentryx, Inc. in 2016 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 13 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 13

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

9% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 11

1% less funds holding

Funds holding: 7271 (-1)

70% less capital invested

Capital invested by funds: $203M → $61.3M (-$142M)

90% less call options, than puts

Call options by funds: $15K | Put options by funds: $155K

Holders
71
Holders Change
-1
Holders Change %
-1.39%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
10
Increased
29
Reduced
13
Closed
11
Calls
$15K
Puts
$155K
Net Calls
-$140K
Net Calls Change
+$182K
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$228K +$124K +34,113 +59%
JP Morgan Chase
27
JP Morgan Chase
New York
$215K +$14.4K +3,951 +5%
Citadel Advisors
28
Citadel Advisors
Florida
$176K +$115K +31,652 +81%
Ohio Public Employees Retirement System (OPERS)
29
Ohio Public Employees Retirement System (OPERS)
Ohio
$173K -$19K -5,230 -7%
Goldman Sachs
30
Goldman Sachs
New York
$166K +$172K +47,275 +243%
Two Sigma Investments
31
Two Sigma Investments
New York
$158K +$113K +31,080 +96%
California Public Employees Retirement System
32
California Public Employees Retirement System
California
$156K
Parallax Volatility Advisers
33
Parallax Volatility Advisers
California
$151K
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$149K +$28.7K +7,873 +15%
TC
35
TFS Capital
Pennsylvania
$141K +$207K +56,709 New
KeyBank National Association
36
KeyBank National Association
Ohio
$140K +$65.1K +17,883 +47%
BPC
37
Banque Pictet & Cie
Switzerland
$135K
BCM
38
Bridgeway Capital Management
Texas
$125K
BBA
39
Baker Bros. Advisors
New York
$122K
LCM
40
Landscape Capital Management
New Jersey
$113K +$166K +45,518 New
TA
41
Teachers Advisors
New York
$102K
ProShare Advisors
42
ProShare Advisors
Maryland
$89K -$13.5K -3,714 -9%
Charles Schwab
43
Charles Schwab
California
$88K
RA
44
Royce & Associates
New York
$82K -$1.46K -400 -1%
Citigroup
45
Citigroup
New York
$72K +$77.5K +21,284 +289%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$71K
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$63K
RFC
48
Russell Frank Company
Washington
$61K +$88.5K +24,300 New
DekaBank Deutsche Girozentrale
49
DekaBank Deutsche Girozentrale
Germany
$58K +$9.11K +2,500 +11%
PBT
50
Pictet Bank & Trust
Bahamas
$52K

CCXI Hedge Fund Activity: Q1 2016 in Review

71 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q1 2016, worth a combined $61.3M — down 70% from $203M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of CCXI and 10 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 29 added.

The largest buyer was BVF Inc, adding an estimated $5.48M. The largest seller was Westfield Capital Management, exiting entirely with an estimated $8.93M sold.

  • 71 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q1 2016, down from 72 in Q4 2015.
  • Funds reported $61.3M of ChemoCentryx, Inc. stock for Q1 2016, down 70% quarter-over-quarter.
  • 10 funds opened new ChemoCentryx, Inc. positions in Q1 2016 and 11 closed out, a net change of -1 holder.
  • The largest ChemoCentryx, Inc. buyer in Q1 2016 was BVF Inc, an estimated $5.48M added.
  • The largest ChemoCentryx, Inc. seller in Q1 2016 was Westfield Capital Management, an estimated $8.93M sold.

Based on aggregated 13F filings for Q1 2016.